A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).
ClinicalTrials.gov · NCT07081178 · Registry updated: 2026-04-27
- Condition / research focus
- Obesity
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- Germany
- Registry dates and results
- Start: 2025-08-08. Completion: 2025-12-18 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Semaglutide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Medizinisches Versorgungszentrum Am Bahnhof Spandau GbR
Berlin, Germany
Site recruitment: Not reported